GNLX vs NTRS · rev $8.0K vs P/E 18, rev $2.69B
Genelux Corporation Common Stock (GNLX) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
GNLX currently screens at market cap $130.6M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the GNLX and NTRS stock pages for the full models.
Not investment advice.